Q2 2025 KP Tissue Inc Earnings Call Transcript
Key Points
- Adjusted EBITDA improved by double digits year over year to $72.5 million.
- US sales have grown 12% after six months into 2025, representing a key growth driver.
- Revenue growth of over 5% in Q2 2025 was driven by higher sales volume and favorable selling prices.
- Canada revenue grew 7.4% in the second quarter, while US sales rose 2.4% year-over-year.
- The company announced a $35 million investment in the Memphis facility to enhance efficiency and support US business growth.
- US revenue growth slowed in Q2 2025 due to front-loaded shipments and softness in the away from home market.
- Higher pulp prices and unfavorable mill performance at the Memphis site negatively impacted profitability.
- Away from home segment revenue decreased 1.1% year-over-year due to lower sales volume.
- Sequentially, adjusted EBITDA decreased by 4.3% due to higher manufacturing overhead costs and lower US sales volume.
- The cash position decreased significantly from $141.8 million to $85.3 million due to a movement to a restricted cash account.
Good morning and welcome to KP Tissue's Second quarter 2025 results conference call.(Operator Instruction) I will now turn the call over to Doris Gerbick, Director of Investor Relations. You may begin your conference.
Thank you, operator. Good morning, everyone, and thank you for joining us to review Kruger Products Second quarter 2025 financial results. With me this morning is Dino Bianco, the CEO of KP Tissue and Kruger Products. And Michael Keays, the CFO of KP Tissue and Kruger Products.
Today's discussion will include certain forward-looking statements. Actual results could differ materially from these forward-looking statements due to known and unknown risks and uncertainties. A list of risk factors can be found in our public filings.
In addition, today's discussion will include certain non-GAAP financial measures. The reconciliation of these non-GAAP financial measures to the most comparable GAAP measure can be found in our MD&A.
The press release reporting our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
